CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives A prospective natural-history study of coronary atherosclerosis Sudden Cardiac Arrest Survivorship: A Scientific Statement From the American Heart Association Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)he management of patients with) Management of No-Reflow Phenomenon in the Catheterization Laboratory Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study

Original Research2016 Dec;255:73-79.

JOURNAL:Atherosclerosis. Article Link

Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study

Nakanishi R, Ceponiene I, Osawa K et al. Keywords: coronary computed tomography angiography; Diabetes; Plaque progression

ABSTRACT


BACKGROUND AND AIMS - We aimed at investigating whether diabetes is associated with progression in coronary plaque components.

 

METHODS - We identified 142 study subjects undergoing serial coronary computed tomography angiography. The resulting propensity score was applied 1:1 to match diabetic patients to non-diabetic patients for clinical risk factors, prior coronary stenting, coronary arterycalcium (CAC) score and the serial scan interval, resulting in the 71 diabetes and 71 non-diabetes patients. Coronary plaque (total, calcified, non-calcified including fibrous, fibrous-fatty and low attenuation plaque [LAP]) volume normalized by total coronary arterylength was measured using semi-automated plaque software and its change overtime between diabetic and non-diabetic patients was evaluated.

 

RESULTS - The matching was successful without significant differences between the two groups in all matched variables. The baseline volumes in each plaque also did not differ. During a mean scan interval of 3.4 ± 1.8 years, diabetic patients showed a 2-fold greater progression in normalized total plaque volume (TPV) than non-diabetes patients (52.8 mm3vs. 118.3 mm3, p = 0.005). Multivariable linear regression model revealed that diabetes was associated with normalized TPV progression (β 72.3, 95%CI 24.3-120.3). A similar trend was observed for the non-calcified components, but not calcified plaque (β 3.8, 95%CI -27.0-34.7). Higher baseline CAC score was found to be associated with total, non-calcified and calcified plaque progression. However, baseline non-calcified volume but not CAC score was associated with LAP progression.

 

CONCLUSIONS - The current study among matched patients indicates diabetes is associated with a greater plaque progression. Our results show the need for strict adherence of diabetic patients to the current preventive guidelines.

 

Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.